missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ CTS™ (Cell Therapy Systems) Dynabeads™ CD3/CD28

Numéro de catalogue. 40203D
Modifier l'affichage
Click to view available options
Quantité:
10 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
40203D 10 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. 40203D Fournisseur Gibco™ Code fournisseur 40203D

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

CTS™ Dynabeads™ CD3/CD28 are intended for ex vivo isolation, activation, and expansion of human T-cells in translational research.

CTS™ Dynabeads™ CD3/CD28 are intended for ex vivo isolation, activation, and expansion of human T-cells in translational research. The technology—previously known as Xcyte™ Dynabeads™ or Dynabeads™ ClinExVivo™ CD3/CD28—has been used in a number of clinical studies. By combining anti-CD3 and anti-CD28 antibodies on Dynabeads, the beads provide both the primary and co-stimulatory signals that are required for activation and expansion of T cells. CTS Dynabeads CD3/CD28 are manufactured and controlled according to ISO 9001:2000 and ISO 13485:2012 requirements. A Device Master File is held with the FDA for cross-referencing in IND applications, and a CoA is available on request. In the US, CTS Dynabeads CD3/CD28 are available for clinical use only under an approved Investigational New Drug (IND) application. Dynabeads™ Human T-Expander CD3/CD28 (Cat. No. 11141D) is the research grade version of CTS Dynabeads CD3/CD28, containing the same amount and ratio of antibodies from the same clones as CTS Dynabeads CD3/CD28, and intended for small scale pre-clinical research.

Applications:

The CTS Dynabeads CD3/CD28 technology has been successfully used in ex vivo isolation, activation, and expansion of T-cells in a number of studies, including studies on HIV infection and cancer. Other potential applications for this novel technology include research into treatment of autoimmune and infectious diseases and prevention of complications associated with chemotherapy and allogeneic stem cell transplantation.

Spécifications

Type de cellules T Cells (Whole Population)
Clonage Monoclonal
Contenu et stockage The product contains: CTS Dynabeads CD3/CD28 supplied as a sterile, non-pyrogenic suspension containing 4 x 108 Dynabeads/mL in phosphate buffered saline (PBS), pH 7.4, with 0.1% recombinant human serum albumin (rHSA).

Store at: 2-8°C.
Type de produit Antibody Coated Bead
Type de produit final Cells
Gamme de produit CTS, DYNAL, Dynabeads
Quantité 10 mL
Réactivité Human
Type d’échantillon Cell Cultures, Clinical Sample, PBMC
Shipping condition (Condition d'expédition) Wet Ice
Espèces cibles Human
Afficher plus de résultats Afficher moins de résultats

For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.